The theory of evolution by natural selection asserts that the immense molecular variation retained by organisms is potentially important to their ability to adapt (Lewontin 1974) , while the theory of neutral evolution asserts that most of this variation has no selective value (Kimura 1968). Recent statistical analyses comparing synonymous and nonsynonymous substitutions in the coding and noncoding regions of protein genes (Kreitman and Hudson 1991; McDonald and Kreitman 1991) indicate that even in the absence of function, there is a selective bias against some amino acids yet retention of others. Because a selective mechanism has not been identified, however, these results are difficult to interpret. Here we quantify two independent and alternative selective factors, bioenergetic costs and biosynthetic complexity, that may account for the retention of apparently ''neutral'' amino acids, particularly when they are found in highly expressed proteins.
acids (as well as proteins, nucleotides, and related molecules) and, hence, the costs of molecular variation can be compared.
The second estimate of the economics of amino acid cost is the complexity of the synthesis pathways by which they are produced. We quantify biosynthetic cost by counting the total number of enzymes required for each synthesis pathway (table 1) .
Although evolution toward reduced bioenergetic and biosynthetic costs would seem to be a general property of amino acid substitution at unconstrained sites, the effects of cost selection are most likely to be revealed among proteins that are highly expressed. We tested our hypotheses by comparing the metabolic costs and the biosynthetic complexities of specific amino acid substitutions in a complex of proteins produced by two closely related lineages of the colicin gene clusters ColE1 and ColIA, found on plasmids harbored by Escherichia coli. Colicins are toxic proteins produced by, and active against, E. coli and related bacteria (Riley 1993a (Riley , 1993b . Colicin gene clusters, carried exclusively on a diverse group of plasmid replicons, include genes that encode a colicin protein, an immunity protein (providing specific immunity to the host against the action of the colicin), and, in the case of the E1 cluster, a lysis protein (Riley 1993a (Riley , 1993b . Under stress, colicinergic bacteria produce colicin proteins whose release from the cell is mediated by the action of lysis proteins. The colicin proteins are lethal to both the producing cell and any bacteria not immune or resistant to that particular colicin (Nomura 1967; Pugsley 1984; Riley 1993a Riley , 1993b .
The total numbers of NADHs, NADPHs, GTPs, and ATPs required for synthesis of each of the amino acid is based on data tabulated by Neidhardt, Ingraham, and Schaechter (1990, pp. 138-140 ; table 1). Thus, the synthetic cost of any amino acid is the sum of the number of ATPs sacrificed when the amino acid's starting metabolite is diverted from one of the three metabolic pathways plus the number of ATP equivalents directly invested in its synthesis, subtracted from the number of ATPs gained prior to metabolite diversion. Additional costs include ATP equivalents calculated for NADH and NADPH, as well as transamination costs (which vary depending on number of NH 4 s ϩ ), sulfurization costs, and the costs of multiple starting metabolites (table 1) .
The energetic costs of the amino acids synthesized by E. coli vary between 78.5 ATP equivalents (tryptophan) and 1 ATP equivalent (aspartate), while the number of biosynthetic steps varies between 12 (tryptophan) and 1 (aspartate, glutamate, alanine, asparagine, histidine). The correlation between energy expended in amino acid synthesis and number of synthetic steps (r ϭ 0.3583, Spearman test statistic) is nonsignificant (for P 
a Modified from Neidhardt, Ingraham, and Schaechter (1990, pp. 138-140) and Zubay (1993; p. 135) ; metabolite data and costs extracted from Stryer (1995, pp. 713-738) .
b ␣kg, ␣-ketogluterate (9.5 ATPs); acCoA, acetyl-CoA (12 ATPs); eryP, erythrose 4-phosphate (28 ATPs); gly-3p, glycerate-3-phosphate (14.5 ATPs); oaa, oxaloacetate (2 ATPs); penP, ribose 5-phosphate (30 ATPs); pep, phosphenylpyruvate (14.5 ATPs); pyr, pyruvate (13.5 ATPs). Ͻ 0.05, r ϭ 0.3688), although borderline, at the 0.05 level.
We compared the biosynthetic and bioenergetic costs of each amino acid substitution in the ColE1 and ColIa lineages that were documented by Riley, Tan, and Wang (1994) . We found that among the E1 colicin proteins, replacement amino acids required significantly fewer steps to synthesize, regardless of their ATP costs ( 2 ϭ 6.25, df ϭ 1, P Ͻ 0.025). In contrast, the cost of the replacement amino acids in the ColE1 lysis and immunity proteins and the cost of the replacement amino acids in the ColIa immunity proteins varied randomly. Comparison of the average bioenergetic and biosynthetic cost per site (table 2) shows that ColE1 and ColIa expend the same amount of energy (17 ATPs) and the same number of synthetic steps (five) per amino acid site to produce colicin proteins. In both cases, this is less than the average (24 ATPs) or median (18.5 ATPs) amount of energy needed for amino acid synthesis in general. The average number of synthetic steps needed to produce the ColE1 and ColIa colicins is approximately equal to the median synthetic step number needed for the synthesis of amino acids in general.
The immunity proteins exhibit a different pattern: the average energy cost per site of ColIa immunity proteins is significantly higher than that of the ColE1 immunity proteins (Mann-Whitney, P Ͻ 0.001) and, in fact, is higher than the cost of all other proteins produced by the two gene clusters. Furthermore, the number of synthetic steps required to produce ColE1 and ColIa immunity proteins is higher than the average number of steps required to produce either lysis or colicin proteins and is well above the median step value for amino acid synthesis in general. This fact is consistent with the hypothesis that ColIa produces more specialized immunity proteins, regardless of bioenergetic or biosynthetic costs, than does ColE1.
Comparative DNA sequence polymorphism data for ColE1 gene clusters shows two groups that differ in 5.4% of their nucleotides. Within-group variation is less, with Ͻ0.2% of base pairs segregating, indicating a more recent common ancestor for group members. A similar pattern of high between-group but low within-group variation is found in the ColIa gene clusters (Riley, Tan, and Wang 1994) . Riley, Tan, and Wang suggest three alternative hypotheses to explain this variation: a more recent origin of ColIa, a smaller effective plasmid or host population size for ColIa, or recent and periodic selection events purging variation in the ColIa plasmid population. Because ColE1 occurs in multiple copies within a bacterial cell, as well as in roughly twice as many E. coli isolates as does ColIa, Riley, Tan, and Wang (1994) propose that the different levels of variation are most likely to result from different population sizes, while the different patterns of polymorphism support the hypothesis that colicin gene clusters evolve under the influence of diversifying selection.
We suggest an alternative, simpler hypothesis consistent with the degree of nucleotide divergence observed in the ColE1 and ColIA sequence trees, but based on the biosynthetic and bioenergetic data. We propose that the two gene clusters ColE1 and ColIa illustrate different stages in evolution. The relatively undifferentiated ColE1 protein lineage, together with its high rate of amino acid subsitution, may reflect a recent ancestry. Here, selection favors biosynthetic simplicity (as measured by step) but not selection for reduced energetic costs. This result could be predicted for the evolution of a compound used in defense, and particularly for an induced defense produced by an organism maintained in an energy-rich environment. In contrast, ColIa colicin proteins may reflect an older evolutionary origin, as indicated by their high degree of divergence and low rate of amino acid substitution. Having already achieved local bioenergetic and biosynthetic minima, ColIa differentiation reflects substitutions occurring only at the nucleotide level (the level at which evolutionary divergence is measured) and in the absence of change in the proteins actually transcribed (the level which is physiologically meaningful to the organism).
